Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-07-04
2006-07-04
Graser, Jennifer E. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S200100, C424S190100, C435S320100, C435S069100, C435S069300, C435S069700, C435S325000, C435S366000, C536S023700, C536S024100
Reexamination Certificate
active
07070792
ABSTRACT:
The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain ofChlamydia, specificallyC. pneumoniae, employing a vector containing a nucleotide sequence encoding full-length, 5′-truncated or 3′-truncated 76 kDa protein of a strain ofChlamydia pneumoniaeand a promoter to effect expression of the 76 kDa protein gene in the host. Modifications are possible within the scope of this invention.
REFERENCES:
patent: 6559294 (2003-05-01), Griffais et al.
patent: 0 784 059 (1997-07-01), None
patent: WO 98/58953 (1998-12-01), None
Grayston et al., “Evidence That Chlamydia Pneumoniae Causes Pneumonia And Bronchitis”,The Journal of Infectious Diseases, vol. 168(5):1231-1491, (1993).
Campos et al., “a Chlamydial Major Outer Membrane Protein Extract As A Trachoma Vaccine Candidate”,Investigative Ophthalmology&Visual Science, vol. 36(8): (1995).
Grayston et al., “A New Respiratory Tract Pathogen: Chlamydia Pneumoniae Strain TWAR”,The Journal of Infectious Diseases, vol. 161, pp. 618-625, (1990).
T. Marrie, “State-of-the-Art Clinical Article”,Clinical Infectious Diseases, vol. 18, pp. 501-515, (1994).
Wang et al., “Microimmunofluorescence Serological Studies With The Twar Organism”,Chlamydial Infections, pp. 329-333, (1986).
Saikku et al., “Serological Evidence Of An Association Of A Novel Chlamydia, Twar, With Chronic Coronary Heart Disease And Acute Myocardial Infarction”,The Lancet, pp. 983-985, (1988).
Thom et al., “Association of Prior Infection With Chlamydia Pneumoniae And Angiographically Demonstrated Coronary Artery Disease”,JAMA, vol. 268(1):68-72.
Kuo et al., “Demonstration of Chlamydia Pheumoniae In Atherosclerotic Lesions Of Coronary Arteries”,The Journal of Infectious Diseases, vol. 167:841-849, (1993).
Kuo et al., “Detection of Chlamydia Pneumoniae In Aortic Lesions of Atherosclerosis By Immunocytochemical Stain”,Arteriosclerosis and Thrombosis, vol. 13(10):1501-1504, (1993).
Campbell et al., “Detection Of Chlamydia Pneumoniae TWAR In Human Coronay Atherectomy Tissues”,The Journal Of Infectious Diseases, vol. 172:585-588, (1995).
Chiu et al., “Chlamydia Pneumoniae, Cytomegalovirus, And Herpes Simplex Virus In Atherosclerosis Of The Carotid Artery”,Circulation, vol. 96(7):2144-2148, (1997).
Ramirez, “Isolation Of Chlamydia Pneumoniae From The Coronary Artery Of A Patient With Coronary Atherosclerosis”,Ann. Intern. Med., vol. 125:979-982, (1996).
Jackson et al., Abst. K121, p. 272, 36thICAAC, Sep. 15-18, 1996, New Orleans.
Fong et al., “Rabbit Model For Chlamydia Pneumoniae Infection”,Journal Of Clinical Microbiology, vol. 35(1):48-52, (1997).
Hahn et al., “Evidence For Chlamydia Pneumoniae Infection In Steroid-Dependent Asthma”,Ann. Allergy Asthma Immunol., vol. 80(1):45-49, (1998).
Hahn et al., “Association Of Chlamydia Pneumoniae IgA Antibodies With Recently Symptomatic Asthma”,Epidemiol. Infect., vol. 117:513-517, (1996).
Bjoernsson et al., “Serology Of Chlamydia In Relation To Asthma And Bronchial Hyperresponsiveness”,Scand. J. Infect. Dis., vol. 28:63-69, (1996).
Hahn, “Treatment Of Chlamydia Pneumoniae Infection In Adult Asthma: A Before-After Trail”,J. Fam. Pract., vol. 41(4):345-351, (1995).
Linnanmaeki et al., “Chlamydia Pneumoniae-Specific Criculating Immune Complexes In Patients With Chronic Coronary Heart Disease”,Circulation, vol. 87(4):1130-1134, (1993).
Saikku et al., “Annals Of Internal Medicine”,American College of Physicians, vol. 116(4):273-278, (1992).
Melnick et al., “Past Infection by Chlamydia Pneumoniae Strain TWAR and Asymptomatic Carotid Atherosclerosis”,The American Journal of Medicine, vol. 95:499-504, (1993).
Shor et al., “Detection of Chlamydia Pneumoniae In Coronary Arterial Fatty Streaks And Atheromatous Plaques”,South African, Medical Journal, vol. 82:158-161, (1992).
Allegra et al., “Acute Exacerbations Of Asthma In Adults: Role Of Chlamydia Pneumoniae Infection”,Eur.Respir. J., vol. 7(12): 2165-2168, (1994).
Hahn et al., “Association of Chlamydia Pneumoniae (Strain TWAR) Infection With Wheezing, Asthmatic Bronchitis, and Adult-Onset Asthma”,JAMA, vol. 266(2):225-230, (1991).
Pal et al., “Intranasal Immunization Induces Long-Term Protection In Mice Against A Chlamydia Trachomatis Genital Challenge”,Infection And Immunity, vol. 64(12):5341-5348, (1996).
Jones et al., “Efficacy Trials With Tissue-Culture Grown, Inactivated Vaccines Against Chlamydial Abortion In Sheep”,Vaccine, vol. 13(8):715-723, (1995).
Igietseme et al., “Resolution Of Murine Chlamydial Genital Infection By The Adoptive Transfer Of A Biovar-Specific, TH1 Lymphocyte Clone”,Regional Immunology, vol. 5:317-324, (1993).
Magee et al., “Chlamydia Trachomatis Pneumonia In The Severe Combined Immunodeficiency (SCID) Mouse”,Reg. Immunol., vol. 5:305-311, (1993).
Gaydos et al., “Similarity of Chlamydia Pneumoniae Strains In The Variable Domain IV Region Of The Major Outer Membrane Protein Gene”,Infection And Immunity, vol. 60(12):5319-5323, (1992).
Database Trembl ‘Online!’EBI, Hinxton, U.K.; May 1, 1999; XP002150537; CHLPN 76 KDA Homolog_1 (CT622).
Perez, Melgoza M. et al., “Isolation and Characterization of a Gene Encoding a Chlamydia pneumoniae 76-Kilodalton Protein Containing a Species-Specific Epitope”,Infection and Immunity, Mar. 1, 1994, US, American Society for Microbiology, Washington, vol. 62, No. 3, pp. 880-886.
Kalman et al.,Nature Genetics, Apr. 1999, 21:385-389.
Casey et al., “Rates Of Formation And Thermal Stabilities Of RNA:DNA and DNA:DNA Duplexes At High Concentrations Of Formamide”,Nucleic Acids Research, vol. 4(5):1539-1553, (1977).
Cagnon et al., “A New Family Of Sugar-Inducible Expression Vectors ForEscherichia coli”, Protein Engineering, vol. 4(7):843-847, (1991).
Wiedmann-Al-Ahmad et al., “Reactions of Polyclonal And Neutralizing Anti-p54 Monoclonal Antibodies With An Isolated, Species-Specific 54-Kilodalton Protein Of Chlamydia Pneumoniae”,Clinical And Diagnostic Laboratory Immunology, vol. 4(6):700-704, (1997).
Hughes et al., “Synthetic Peptides Representing Epitopes Of Outer Membrane Protein F Of Pseudomonas Aeruginosa That Elicit Antibodies Reactive With Whole Cells Of Heterologous Immunotype Strains of P.Aeruginosa”, vol. 60(9):3497-3503, (1992).
Dion et al., “Virus Envelope-Based Peptide Vaccine Against Virus-Induced Mammary Tumors”,Virology, vol. 179:474-477, (1990).
Snijders et al., “Identification Of Linear Epitopes On Semliki Forest Virus E2 Membrane Protein And Their Effectiveness As A Synthetic Peptide Vaccine”,Journal of General Virology, vol. 72:557-565, (1991).
Langeveld et al., “Effective Induction of Neutralizing Antibodies With The Amino Terminus Of VP2 Of Canine Parovirus As A Synthetic Peptide”,Vaccine, vol. 12(15):1473-1480, (1994).
Ausubel et al., “Analysis Of DNA Sequences By Blotting And Hybridization”,Current Protocols In Molecular Biology, pp. 2.9.1-2.9.15, (1994).
Klunkel, “Rapid And Efficient Site-Specific Mutagenesis Without Phenotypic Selection”,Proc. Natl. Acad. Sci. USA, vol. 82:488-492, (1985).
Silhavy et al., “Experiments With Gene Fusions”,Cold Spring Harbor Laboratory, pp. 191-195, (1984).
Landers et al., “Role of L3T4-Bearing T-Cell Populations In Experimental Murine Chlamydial Salpingitis”,Infection and Immunity, vol. 59(10):3774-3777, (1991).
Magee et al., “Role Of CD8 T Cells In Primary Chlamydia Infection”,Infection and Immunity, vol. 63(2):516-521, (1995).
Cotter et al., “Protective Efficacy of Major Outer Membrane Protein
Dunn Pamela
Murdin Andrew D.
Oomen Raymond P.
Wang Joe
Graser Jennifer E.
Sanofi Pasteur Limited
LandOfFree
Chlamydia antigens and corresponding DNA fragments and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chlamydia antigens and corresponding DNA fragments and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia antigens and corresponding DNA fragments and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3575089